ZTS insider ownership: who sold, why, and what they still hold

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Julie Fuller Executive Vice President	274	$69.83	15%	1.6K	Sep 30, 2026	Oct 2, 2026

What stands out

Three directors bought shares: Frank Damelio (6.7K shares, $501K), Michael McCallister (3K shares, $233K) and Paul Bisaro (2K shares, $152K). These are the first by current officers or directors since Feb 19, 2021.Frank Damelio: purchase, May 13, 2026 · Michael McCallister: purchase, May 11, 2026 · Paul Bisaro: purchase, May 13, 2026

Kristin Peck sold 20K shares (21% of starting holdings), but 39K more shares were added, so the stake grew (from 95K to 106K).Largest sale, Feb 17, 2026

Percentages cover 20 of 26 officers and directors. 6 are left out

Left out: Jamie Brannan (holdings couldn't be fully reconciled); Khosla Sanjay (most holdings were last confirmed in 2021); Abhay Nayak, Mark Stetter, Stephanie Tilenius and James Saccaro (held no vested shares at the start).

Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Each bar is 100% of that person's own stake; not comparable between people. The stake is the vested shares held at the start of the period (Oct 9, 2025); the gold part is what they sold.

SoldRest of starting stakeAdded during the period

Kristin Peck

Chief Executive Officer, Director

Sold 21%, but 39K shares were added (mostly vesting), so the stake grew

21% · $2.5MDisclosed plan

Amounts, filings and trading plans for each seller

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled

Common questions

Is the Zoetis CEO selling stock?

Yes. Kristin Peck sold 20K shares ($2.5M, 21% of starting holdings) in the past 12 months, all of it under a trading plan disclosed in the filings.

Why are Zoetis insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 100% of sales by value ran under 10b5-1 trading plans disclosed in the filings. A trading plan schedules sales in advance.

Are any Zoetis insiders buying?

Yes. 3 officers or directors reported 3 purchases in the past 12 months (Form 4 code P, which includes private purchases).

How much of their stake did Zoetis insiders sell?

About 6.8% overall. As a group they ended with more shares than they started with. The biggest individual seller, Kristin Peck, sold shares equal to 21% of starting holdings, but more shares were added, so the stake grew. That covers the 12 months to Oct 9, 2026 and counts vested shares reported on SEC Forms 3, 4 and 5, which is not an insider's whole wealth.

The evidence

Who sold1 officer or director: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
Kristin Peck Chief Executive Officer, Director	$2.5M 20K shares	21%	Disclosed plan

The full ownership picture25 of 26 insiders fully reconciled · 22 officers and directors

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Oct 9, 2025

Sold

Held Oct 9, 2026

Still held

Kristin Peck

Minor difference of 22 shares. Difference is under 0.5% of holdings.

Chief Executive Officer, Director

95K

−20K

106K

+11%

Vesting, gifts, unvested awards and holding lines for Kristin Peck

+39Kshares vested or exercised

0gifted (net of own trusts)

−8.3Kwithheld by the company for taxes

139K → 196Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	94,194	105,068
401(k)	Common Stock	812	834

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
249,632	n/a	n/a	n/a
67,148	$162.07	n/a	$0
62,500	$196.14	n/a	$0
84,711	$156.64	n/a	$0
111,060	$129.13	n/a	$0

Estimate: options held × ($75.39 − strike price), using the most recent insider trade price on Form 4 (May 13, 2026), not a market close.

Reconciliation: minor difference of 22 shares. Difference is under 0.5% of holdings.

Robert Scully

Director

29K

no sales

Vesting, gifts, unvested awards and holding lines for Robert Scully

0shares vested or exercised

0gifted (net of own trusts)

20K → 20Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	21,489	21,489
trust	Common Stock	7,590	7,590

Michael McCallister

Minor difference of 1,209 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Director

28K

32K

no sales

Vesting, gifts, unvested awards and holding lines for Michael McCallister

+1.6Kshares vested or exercised

−1.2Kgifted (net of own trusts)

4K → 6Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	3	0
trust	Common Stock	27,684	31,893

Reconciliation: minor difference of 1,209 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Paul Bisaro

Director

24K

28K

no sales

Vesting, gifts, unvested awards and holding lines for Paul Bisaro

+1.6Kshares vested or exercised

0gifted (net of own trusts)

4K → 6Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	24,243	27,862

Wetteny Joseph

Chief Financial Officer

19K

22K

no sales

Vesting, gifts, unvested awards and holding lines for Wetteny Joseph

+4.8Kshares vested or exercised

0gifted (net of own trusts)

−1.7Kwithheld by the company for taxes

64K → 82Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	18,967	22,113

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
15,208	$162.07	n/a	$0
15,625	$196.14	n/a	$0
11,243	$201.30	n/a	$0
23,625	$156.64	n/a	$0
34,045	$129.13	n/a	$0

Estimate: options held × ($75.39 − strike price), using the most recent insider trade price on Form 4 (May 13, 2026), not a market close.

Gregory Norden

Minor difference of 1,213 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Director

17K

18K

no sales

Vesting, gifts, unvested awards and holding lines for Gregory Norden

+1.6Kshares vested or exercised

−1.2Kgifted (net of own trusts)

4K → 6Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	0	0
personal trust	Common Stock	5,858	7,071
daughter's trust	Common Stock	5,548	5,548
son's trust	Common Stock	5,548	5,548

Reconciliation: minor difference of 1,213 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Louise Parent

Director

15K

28K

no sales

Vesting, gifts, unvested awards and holding lines for Louise Parent

+14Kshares vested or exercised

0gifted (net of own trusts)

4K → 6Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	15,260	28,394

Roxanne Lagano

Minor difference of 14 shares. Difference is under 0.5% of holdings.

Executive Vice President

15K

16K

no sales

Vesting, gifts, unvested awards and holding lines for Roxanne Lagano

+1.9Kshares vested or exercised

0gifted (net of own trusts)

−696withheld by the company for taxes

36K → 45Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	14,429	15,632
401(k)	Common Stock	820	834

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
20,221	n/a	n/a	n/a
6,542	$162.07	n/a	$0
6,127	$196.14	n/a	$0
8,642	$156.64	n/a	$0
14,499	$129.13	n/a	$0

Estimate: options held × ($75.39 − strike price), using the most recent insider trade price on Form 4 (May 13, 2026), not a market close.

Reconciliation: minor difference of 14 shares. Difference is under 0.5% of holdings.

Frank Damelio

Minor difference of 6,650 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer). Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Director

15K

21K

no sales

Vesting, gifts, unvested awards and holding lines for Frank Damelio

0shares vested or exercised

−6.7Kgifted (net of own trusts)

41K → 65Kunvested awards, start → end

Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	14,808	14,808
Trust	Common Stock	0	6,650

Additional holdings last reported Feb 6, 2013, not confirmed since: 5,000 shares. Not included in any total or percentage on this page.

Direct, Class A Common Stock: 5,000 shares, last reported Feb 6, 2013

Reconciliation: minor difference of 6,650 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Willie Reed

Director

11K

13K

no sales

Vesting, gifts, unvested awards and holding lines for Willie Reed

+1.6Kshares vested or exercised

0gifted (net of own trusts)

4K → 6Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	11,245	12,864

Robert Polzer

Executive Vice President

6.2K

no sales

Vesting, gifts, unvested awards and holding lines for Robert Polzer

0shares vested or exercised

0gifted (net of own trusts)

21K → 21Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	5,120	5,120
401(k)	Common Stock	1,073	1,073

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
5,455	n/a	n/a	n/a
4,840	$162.07	n/a	$0
7,107	$196.14	n/a	$0
13,814	$156.64	n/a	$0
5,455	$201.30	n/a	$0

Estimate: options held × ($75.39 − strike price), using the most recent insider trade price on Form 4 (May 13, 2026), not a market close.

Rimma Driscoll

Executive Vice President

5.2K

5.7K

no sales

Vesting, gifts, unvested awards and holding lines for Rimma Driscoll

+868shares vested or exercised

0gifted (net of own trusts)

−345withheld by the company for taxes

8.3K → 13Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	5,192	5,715

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
5,271	n/a	n/a	n/a
2,077	$162.07	n/a	$0
2,500	$196.14	n/a	$0
5,235	$156.64	n/a	$0
9,191	$129.13	n/a	$0

Estimate: options held × ($75.39 − strike price), using the most recent insider trade price on Form 4 (May 13, 2026), not a market close.

Antoinette Leatherberry

Director

4.1K

5.3K

no sales

Vesting, gifts, unvested awards and holding lines for Antoinette Leatherberry

+1.6Kshares vested or exercised

0gifted (net of own trusts)

9.7K → 12Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	4,067	5,280

Vanessa Broadhurst

Director

2.8K

3.9K

no sales

Vesting, gifts, unvested awards and holding lines for Vanessa Broadhurst

+1.6Kshares vested or exercised

0gifted (net of own trusts)

7.2K → 9.2Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	2,818	3,920

Jamie Brannan

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +27 shares on Feb 8, 2026 (UK Share Ownership Plan). See the filing Sales and other transactions for Jamie Brannan are complete.

Executive Vice President

n/a

Vesting, gifts, unvested awards and holding lines for Jamie Brannan

+2.1Kshares vested or exercised

0gifted (net of own trusts)

−994withheld by the company for taxes

7.6K → 16Kunvested awards, start → end

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +27 shares on Feb 8, 2026 (UK Share Ownership Plan). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	2,171	3,290
UK Share Ownership Plan	Common Stock	418	445

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
6,941	n/a	n/a	n/a
4,103	$162.07	n/a	$0
5,955	$196.14	n/a	$0
13,877	$156.64	n/a	$0
21,361	$129.13	n/a	$0

Estimate: options held × ($75.39 − strike price), using the most recent insider trade price on Form 4 (May 13, 2026), not a market close.

Gavin Hattersley

Director

2.2K

3.4K

no sales

Vesting, gifts, unvested awards and holding lines for Gavin Hattersley

+1.6Kshares vested or exercised

0gifted (net of own trusts)

3K → 5Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	2,216	3,354

Keith Sarbaugh

Executive Vice President

3.3K

no sales

Vesting, gifts, unvested awards and holding lines for Keith Sarbaugh

+2Kshares vested or exercised

0gifted (net of own trusts)

−726withheld by the company for taxes

7.2K → 12Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	2,039	3,346

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
3,142	$166.44	n/a	$0
1,348	$196.14	n/a	$0
4,453	$156.64	n/a	$0
10,581	$129.13	n/a	$0

Estimate: options held × ($75.39 − strike price), using the most recent insider trade price on Form 4 (May 13, 2026), not a market close.

Astorga Ferran

Executive Vice President

1.2K

1.7K

no sales

Vesting, gifts, unvested awards and holding lines for Astorga Ferran

+855shares vested or exercised

0gifted (net of own trusts)

−379withheld by the company for taxes

5.1K → 9Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	1,208	1,684

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
4,057	n/a	n/a	n/a
2,353	$162.07	n/a	$0
2,328	$196.14	n/a	$0
4,973	$156.64	n/a	$0
8,693	$129.13	n/a	$0

Estimate: options held × ($75.39 − strike price), using the most recent insider trade price on Form 4 (May 13, 2026), not a market close.

Nicholas Ashton

Executive Vice President

1.1K

1.8K

no sales

Vesting, gifts, unvested awards and holding lines for Nicholas Ashton

+1.5Kshares vested or exercised

0gifted (net of own trusts)

−801withheld by the company for taxes

6.9K → 13Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	1,094	1,822

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
3,369	n/a	n/a	n/a
4,304	$162.07	n/a	$0
4,289	$196.14	n/a	$0
8,642	$156.64	n/a	$0
16,413	$129.13	n/a	$0

Estimate: options held × ($75.39 − strike price), using the most recent insider trade price on Form 4 (May 13, 2026), not a market close.

Julie Fuller

Executive Vice President

603

1.6K

no sales

Vesting, gifts, unvested awards and holding lines for Julie Fuller

+1.5Kshares vested or exercised

0gifted (net of own trusts)

−564withheld by the company for taxes

11K → 25Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	603	1,588

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
8,642	$156.64	n/a	$0
14,345	$129.13	n/a	$0

Estimate: options held × ($75.39 − strike price), using the most recent insider trade price on Form 4 (May 13, 2026), not a market close.

Kevin Esch

Minor difference of 1 share. Difference is under 0.5% of holdings. Started reporting during the period; starting holdings are from the Form 3.

Executive Vice President

390

702

no sales

Vesting, gifts, unvested awards and holding lines for Kevin Esch

+454shares vested or exercised

0gifted (net of own trusts)

−143withheld by the company for taxes

1.4K → 12Kunvested awards, start → end

Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	267	578
401(k)	Common Stock	123	124

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
1,181	$156.64	n/a	$0
490	$196.14	n/a	$0
545	$162.07	n/a	$0
391	$201.30	n/a	$0
15,931	$129.13	n/a	$0

Estimate: options held × ($75.39 − strike price), using the most recent insider trade price on Form 4 (May 13, 2026), not a market close.

Reconciliation: minor difference of 1 share. Difference is under 0.5% of holdings.

Mark Stetter

Director

1.6K

no sales

Vesting, gifts, unvested awards and holding lines for Mark Stetter

+1.6Kshares vested or exercised

0gifted (net of own trusts)

1.5K → 8.6Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	0	1,572

25 of 26 insiders fully reconciled: starting holdings plus reported transactions match ending holdings (19 exactly, 6 with a minor or footnoted difference). For 1 we show sales but not holdings; the ! icon on that row explains why. Percentages cover 20 of 26 officers and directors. Left out: Jamie Brannan (holdings couldn't be fully reconciled); Khosla Sanjay (most holdings were last confirmed in 2021); Abhay Nayak, Mark Stetter, Stephanie Tilenius and James Saccaro (held no vested shares at the start). "Still held" compares ending with starting vested shares; a plus sign means the holding grew.

What explains the selling$2.5M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $2.5M across 20,000 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

Disclosed plan · $2.5M · 100%

Taxes

14,608 shares ($1.8M) were withheld by the company for taxes, which isn't a market sale.

Purchases · 3 buyers (3 trades)

3 officers and directors bought shares in this period, in 3 trades(Form 4 code P). Across all their filings on record there are 13 purchase trades.

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
Kristin Peck Chief Executive Officer, Director	20K	$2.5M	100%	100%	Feb 17, 2026 to Feb 17, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$0	$0	$0	$0
Nov 2025	$0	$0	$0	$0
Dec 2025	$0	$0	$0	$0
Jan 2026	$0	$0	$0	$0
Feb 2026	$2.5M	$2.5M	$0	$0
Mar 2026	$0	$0	$0	$0
Apr 2026	$0	$0	$0	$0
May 2026	$0	$0	$0	$0
Jun 2026	$0	$0	$0	$0
Jul 2026	$0	$0	$0	$0
Aug 2026	$0	$0	$0	$0
Sep 2026	$0	$0	$0	$0
Oct 2026	$0	$0	$0	$0

Is this normal? Selling year by year5 earlier years to compare with

Less than usual: about one-sixth of the 5-year average. 1 insider sold; the average is 6 a year.

12 months ending	Shares sold	Insiders who sold	Proceeds
Oct 9, 2026 Latest 12 months	20K	1	$2.5M
Oct 9, 2025 1 year earlier	6.4K	4	$1.1M
Oct 9, 2024 2 years earlier	40K	3	$7.2M
Oct 10, 2023 3 years earlier	56K	4	$10.0M
Oct 10, 2022 4 years earlier	124K	9	$24.8M
Oct 10, 2021 5 years earlier	421K	9	$71.4M

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertainty1 insider whose holdings couldn't be fully reconciled

Jamie Brannan: holdings couldn't be fully reconciled (difference of 27 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +27 shares on Feb 8, 2026 (UK Share Ownership Plan). Filing, Feb 8, 2026

Footnote: "Represents the common stock equivalents held in the UK Share Ownership plan, as of December 31, 2025."

Kristin Peck: minor difference of 22 shares. Difference is under 0.5% of holdings.

Michael McCallister: minor difference of 1,209 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Gregory Norden: minor difference of 1,213 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Roxanne Lagano: minor difference of 14 shares. Difference is under 0.5% of holdings.

Frank Damelio: minor difference of 6,650 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Kevin Esch: minor difference of 1 share. Difference is under 0.5% of holdings.

Inferred rename: the share class "Class A Common Stock" is treated as the same class as "Common Stock" on 7 holding lines, because the old title was never reported again on those lines and each balance carried over exactly. Example (Catherine Knupp, 1,000 shares): old title, new title

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology1,611 filings from SEC EDGAR, and how we read them

All 1,611 Forms 3, 4 and 5 filed for Zoetis (SEC CIK 1555280) from Jan 31, 2013 to Oct 2, 2026, retrieved from SEC EDGAR on Oct 9, 2026. Prices are the ones reported in each filing, often weighted averages.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (28)No filing in 18 months; last reported balances, not in any total

Name	Last filed	Last reported balance
Wafaa Mamilli	Oct 8, 2024	6,685 shares, last reported balance as of Feb 10, 2024
Soria Banque	Oct 8, 2024	588 shares, last reported balance as of Jul 31, 2024
Linda Rhodes	May 22, 2024	11,192 shares, last reported balance as of May 21, 2024
Heidi Chen	Apr 9, 2024	35,705 shares, last reported balance as of Feb 10, 2024
Glenn David	Jan 18, 2023	48,933 shares, last reported balance as of Feb 23, 2022
Timothy Bettington	Oct 11, 2022	No balance on record
Roman Trawicki	Mar 18, 2022	8,218 shares, last reported balance as of Mar 16, 2022
Catherine Knupp	Nov 12, 2021	43,737 shares, last reported balance as of Nov 10, 2021
Sherry Pudloski	Oct 12, 2021	No balance on record
Juan Alaix	May 24, 2021	215,129 shares, last reported balance as of May 20, 2021
William Steere Jr.	May 24, 2021	35,074 shares, last reported balance as of May 20, 2021
Robert Kelly	May 4, 2021	9,127 shares, last reported balance as of May 3, 2021
James McFarland	Apr 13, 2021	3,246 shares, last reported balance as of Feb 13, 2021
Clinton Lewis Jr.	Dec 18, 2019	27,936 shares, last reported balance as of Dec 16, 2019
Andrew Fenton	Dec 10, 2019	23,262 shares, last reported balance as of Dec 6, 2019
Alejandro Bernal	Mar 1, 2018	11,417 shares, last reported balance as of Feb 27, 2018
Paul Herendeen	Jul 20, 2016	No balance on record
William Doyle	May 12, 2016	No balance on record
Pershing Square Capital Management, L.P.	May 10, 2016	66,796,290 shares, last reported balance as of May 9, 2016
Sandra Beaty	May 1, 2015	9,323 shares, last reported balance as of Feb 23, 2015
Joyce Lee	Apr 10, 2015	3,838 shares, last reported balance as of Feb 23, 2015
Stefan Weiskopf	Mar 3, 2015	3,658 shares, last reported balance as of Feb 23, 2015
Richard Passov	Jul 16, 2014	3,706 shares, last reported balance as of Feb 25, 2014
PFIZER INC	Jun 26, 2013	500,000,000 shares, last reported balance as of Jan 31, 2013
Geno Germano	Feb 8, 2013	5,000 shares, last reported balance as of Feb 6, 2013
Douglas Giordano	Feb 8, 2013	5,000 shares, last reported balance as of Feb 6, 2013
Charles Hill	Feb 8, 2013	5,000 shares, last reported balance as of Feb 6, 2013
Amy Schulman	Feb 8, 2013	5,000 shares, last reported balance as of Feb 6, 2013

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.

Zoetis insiders sold $2.5M in the past 12 months. How much of their stake is that?

What stands out

Who sold, and how much of their stake

Selling by month

Common questions

Is the Zoetis CEO selling stock?

Why are Zoetis insiders selling?

Are any Zoetis insiders buying?

How much of their stake did Zoetis insiders sell?

The evidence

Taxes

Purchases · 3 buyers (3 trades)

Sales by month